Daiichi Life Group Inc. offered to buy the remainder of Challenger Ltd. that it doesn’t already own, in a takeover bid that valued the Australian firm at around A$7.9 billion ($5.5 billion).
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.